Last reviewed · How we verify
Clopidogrel dose adjustment
Clopidogrel dose adjustment is a Small molecule drug developed by University of Zagreb. It is currently FDA-approved. Also known as: antiplatelet therapy tailoring.
Clopidogrel is used to treat conditions such as coronary artery disease, acute coronary syndrome, and ST-elevation myocardial infarction. The standard dose of clopidogrel is not specified in the provided facts, but it is a small molecule used in combination with aspirin for antiplatelet treatment.
At a glance
| Generic name | Clopidogrel dose adjustment |
|---|---|
| Also known as | antiplatelet therapy tailoring |
| Sponsor | University of Zagreb |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant (PHASE4)
- Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE) (PHASE3)
- Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke (PHASE3)
- Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND (PHASE3)
- Effect of Oral Antiplatelet or Anticoagulant Drugs on Postoperative Bleeding Risk and Venous Closure Rate in Patients With Lower Extremity Varicose Veins After Radiofrequency Ablation
- Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study (PHASE4)
- Traditional Chinese Medicine Intervention for Ischemic Cardiovascular Disease Comorbid With Diabetes Mellitus: An Efficacy Comparative Study (PHASE4)
- Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clopidogrel dose adjustment CI brief — competitive landscape report
- Clopidogrel dose adjustment updates RSS · CI watch RSS
- University of Zagreb portfolio CI
Frequently asked questions about Clopidogrel dose adjustment
What is Clopidogrel dose adjustment?
Who makes Clopidogrel dose adjustment?
Is Clopidogrel dose adjustment also known as anything else?
What development phase is Clopidogrel dose adjustment in?
Related
- Manufacturer: University of Zagreb — full pipeline
- Also known as: antiplatelet therapy tailoring
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing